Evidence map›Paper›PMID 36078427›Full record

ReviewInternational journal of environmental research and public health2022

Update on COVID-19 and Effectiveness of a Vaccination Campaign in a Global Context.

Ioannis Alexandros Charitos, Andrea Ballini, Roberto Lovero, Francesca Castellaneta, Marica Colella, Salvatore Scacco, Stefania Cantore, Roberto Arrigoni, Filiberto Mastrangelo, Mario Dioguardi

Open access · goldAbstract readReview
In one paragraph

Review in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Biomolecular Actions by Intestinal Endotoxemia in Metabolic Syndrome.International journal of molecular sciences · 2024
    Review
  6. Current Views About the Link between SARS-CoV-2 and the Liver: Friends or Foe?Endocrine, metabolic & immune disorders drug targets · 2024
    Article
  7. Article
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Ioannis Alexandros CharitosDepartment of Emergency and Urgency, National Poisoning Center, Riuniti University Hospital of Foggia, 71122 Foggia, Italy.ORCID 0000-0003-3527-7483
Andrea BalliniDepartment of Precision Medicine, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy.ORCID 0000-0001-8758-1415
Roberto LoveroAOU Policlinico Consorziale di Bari-Ospedale Giovanni XXIII, Clinical Pathology Unit, Policlinico University Hospital of Bari, 70124 Bari, Italy.
Francesca CastellanetaAOU Policlinico Consorziale di Bari-Ospedale Giovanni XXIII, Clinical Pathology Unit, Policlinico University Hospital of Bari, 70124 Bari, Italy.
Marica ColellaInterdisciplinary Department of Medicine, Section of Microbiology and Virology, School of Medicine, University of Bari "Aldo Moro", 70124 Bari, Italy.
Salvatore ScaccoDepartment of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari "Aldo Moro", Piazza G. Cesare 11, 70124 Bari, Italy.ORCID 0000-0003-2717-2489
Stefania CantoreIndependent Researcher, Sorriso & Benessere-Ricerca e Clinica, 70129 Bari, Italy.ORCID 0000-0001-9521-2521
Roberto ArrigoniCNR Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies (IBIOM), 70125 Bari, Italy.
Filiberto MastrangeloDepartment of Clinical and Experimental Medicine, Università degli Studi di Foggia, 71122 Foggia, Italy.ORCID 0000-0002-3746-5675
Mario DioguardiDepartment of Clinical and Experimental Medicine, Università degli Studi di Foggia, 71122 Foggia, Italy.ORCID 0000-0003-0949-3457
Ospedale Pediatrico Giovanni XXIII · ITUniversity of Bari Aldo Moro · ITUniversity of Foggia · ITInstitute of Biomembranes, Bioenergetics and Molecular Biotechnologies · ITOspedali Riuniti di Foggia · ITUniversity of Campania "Luigi Vanvitelli" · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic caused by SARS-CoV-2 remains a significant issue for global health, the economy, and society. When SARS-CoV-2 began to spread, the most recent serious infectious disease of this century around the world, with its high morbidity and mortality rates, it is understandable why such infections have generally been spread in the past, mainly from international travel movements. This perspective review aimed to provide an update for clinicians on the recent developments related to the microbiological perspectives in pandemics, diagnostics, prevention (such as the spread of a virus), vaccination campaigns, treatment options, and health consequences for COVID-19 based on the current literature. In this way, the authors attempt to raise awareness on the transversal nature of these challenges by identifying the main risk/vulnerability factors that the scientific community must face including our current knowledge on the virus capacity of the mechanism of entry into the cells, the current classifications of viral variants, the knowledge of the mathematical model on the spread of viruses (the possible routes of transmission), and the effectiveness of vaccination campaigns in a global context of pandemic, particularly from COVID-19, with a look at new or future vaccines.

Indexed as

COVID-19Global HealthHumansImmunization ProgramsPandemicsSARS-CoV-2Vaccinationclinical microbiologyCOVID-19global healthhuman vaccinespandemicSARS-CoV-2

Identifiers

PMID36078427
PMCPMC9518080
OpenAlexW4293538929

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.